Incretin Mimetics For Type 2 Diabetes
Examples
| Brand Name | Generic Name |
| Byetta | exenatide |
Exenatide is the first of a new type of medication called incretin mimetics. The U.S. Food and Drug Administration (FDA) approved exenatide to treat people with type 2 diabetes who have not been able to control their blood sugar levels with oral medicines. It is given as a shot 2 times a day, before morning and evening meals.
| Last updated: | June 16, 2008 |
|---|---|
| Author: | Caroline Rea, RN, BS, MS |
| Reviewed By: | Caroline S. Rhoads, MD - Internal Medicine, Matthew I. Kim, MD - Endocrinology & Metabolism |
| Editors: | Susan Van Houten, RN, BSN, MBA, Pat Truman, MATC |
© 1995-2007, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.
Drugs & Supplements News
Diseases & Conditions
Getty Images
Get information about ailments that affect your life.
Family Health
Getty Images
Get advice to keep your family healthy on Aol Health.
Best of the Web >>>
-
Quick Links
-
Diet & Fitness
-
On AOL Health
-
On AOL Health
-
Across AOL
-
Across AOL
